Sisram Medical (HKG:1696) opened a new direct office in Thailand and obtained approval for its Profhilo injection from the Thailand Food and Drug Administration, a Monday filing with the Hong Kong Exchange said.
The company plans to get more approvals from Thailand's regulator, while it starts its direct operations in the region with the injectables.
The cosmeceuticals and medical products company's shares were up nearly 5% on Monday's close.
Price (HKD): $4.04, Change: $+0.18, Percent Change: +4.66%